PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2020.10012021532541-548Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer RegistryHyeong In Ha, Eun-Gyeong Lee, Jiwon Lim, So-Youn Jung, Yoon Jung Chang, Young-Joo Won, Myong Cheol Limhttp://e-crt.org/upload/pdf/crt-2020-1001.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2020.1001, http://e-crt.org/upload/pdf/crt-2020-1001.pdf
10.21203/rs.2.24720/v12020Evaluation of pemetrexed in the treatment of epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer: a retrospective studyYanmei Wu, Jie Jianghttps://www.researchsquare.com/article/rs-15278/v1, https://www.researchsquare.com/article/rs-15278/v1.html
Cancers10.3390/cancers14143301202214143301Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal CancerMiklos Acs, Zoltan Herold, Attila Marcell Szasz, Max Mayr, Sebastian Häusler, Pompiliu Pisohttps://www.mdpi.com/2072-6694/14/14/3301/pdf
Gynecologic Oncology10.1016/j.ygyno.2019.04.5462019154235-236Efficacy of second line chemotherapeutic regimens in persistent or recurrent epithelial ovarian cancer including fallopian tube cancer and primary peritoneal cancer: A multicenter retrospective studyH.P. Lee, Y.B. Kimhttps://api.elsevier.com/content/article/PII:S0090825819310443?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0090825819310443?httpAccept=text/plain
BMC Cancer10.1186/s12885-018-4700-32018181Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: a retrospective studyMyong Cheol Lim, Young-Joo Won, Jiwon Lim, Tahereh Salehi, Chong Woo Yoo, Robert E. Bristowhttp://link.springer.com/content/pdf/10.1186/s12885-018-4700-3.pdf, http://link.springer.com/article/10.1186/s12885-018-4700-3/fulltext.html, http://link.springer.com/content/pdf/10.1186/s12885-018-4700-3.pdf
10.21203/rs.3.rs-900227/v12021Characteristics of Second Primary Breast Cancer after Ovarian Cancer: A Korea Central Cancer Registry retrospective studyEun-Gyeong Lee, Jiwon Lim, Hyeong In Ha, Myong Cheol Lim, Yoon Jung Chang, Young-Joo Won, So-Youn Junghttps://www.researchsquare.com/article/rs-900227/v1, https://www.researchsquare.com/article/rs-900227/v1.html
Cancers10.3390/cancers14194638202214194638Primary Treatment Results in Patients with Ovarian, Fallopian or Peritoneal Cancer—Results of a Clinical Cancer Registry Database Analysis in GermanyRobert Armbrust, Peter Ledwon, Anne Von Rüsten, Constanze Schneider, Jalid Sehoulihttps://www.mdpi.com/2072-6694/14/19/4638/pdf
OncoTargets and Therapy10.2147/ott.s7734220152187Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic reviewFlora Zagouri, Theodoros Sergentanis, Dimosthenis Chrysikos, Aristotle Bamias, Athanasios-Meletios Dimopouloshttps://www.dovepress.com/getfile.php?fileID=26628
European Journal of Cancer Supplements10.1016/s1359-6349(05)81203-0200532261908 POSTER A Randomised phase II study of phenoxodiol with platinum or taxane chemotherapy in chemoresistant epithelial ovarian cancer, fallopian tube cancer and primary peritoneal cancerhttps://api.elsevier.com/content/article/PII:S1359634905812030?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634905812030?httpAccept=text/plain
BioDrugs10.1007/s40259-013-0043-42013274375-392Bevacizumab Combination Therapy: A Review of its Use in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerSohita Dhillonhttp://link.springer.com/content/pdf/10.1007/s40259-013-0043-4.pdf, http://link.springer.com/article/10.1007/s40259-013-0043-4/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40259-013-0043-4